Superworth

Fossil price to free cash flow FOSL

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Oct 23, 2026
n/m
not a meaningful number
Last meaningful
1.8×
May 2025
10-year median
4.5×
10-year range
1.0× to 55.5×
Peer median
16.7×

Fossil's price to free cash flow is not a meaningful number today: free cash flow over the last twelve months was zero, negative or not reported.

It was last meaningful in May 2025, at 1.8×.

On the days it had one over the last ten years, its median was 4.5×, from 1.0× in Sep 2024 to 55.5× in Sep 2020.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
20251.8×1.2×2.1×
20241.7×1.0×4.0×
2023n/m a value too high to mean anything
202211.8×11.4×14.2×
202110.0×2.5×10.0×
20202.2×1.9×55.5×
201925.0×2.1×28.8×
20184.6×2.0×15.4×
20172.1×1.8×5.9×
20166.1×5.7×9.1×
20157.1×6.3×17.1×
201417.1×16.1×20.4×
201319.3×15.5×27.1×
201222.6×20.4×60.3×
201130.2×28.3×53.7×

Against its peers

Companies in Medical - Instruments & Supplies nearest Fossil's size, closest first, today.

CompanyPrice to free cash flow
FOSLFossiln/m
EMBCEmbecta2.3×
TCMDTactile Systems Technology20.0×
INFUInfuSystem12.1×
MDXGMimedxn/m
UTMDUtah Medical Products20.6×
MOVMovado9.8×
PDEXPro DEX29.5×
IRMDIradimed43.7×
STAAStaar Surgicaln/m
BVSBioventus13.3×
Peer median16.7×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Fossil

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.